• Intelligent Bio Solutions completed a usability study backing an FDA 510(k) filing for its fingerprint-based drug screening system targeting codeine detection.
• Results were presented now, with the study indicating non-specialist workplace operators could be trained to run tests accurately.
• The milestone supports a planned 510(k) submission in H2 2026, a key step toward U.S. market entry.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Intelligent Bio Solutions Inc. published the original content used to generate this news brief on August 05, 2026, and is solely responsible for the information contained therein.